Fig. 2
From: Clinical significance of FBXO17 gene expression in high-grade glioma

Validation of FBXO17 in multiple external data sets. Kaplan-Meier OS curves after classifying patients into two groups based on FBXO17 gene expression in (a) Rembrandt Set 1 (GBM only), (b) Rembrandt Set 2 (GBM + grade III gliomas), (c) GSE4271, and (d) GSE4412